04/28/2026
Over the past two weeks, I had the distinct privilege of working with students at The Calverton School, continuing a series of seminars on mental health and substance use that I have been delivering for several years.
For most areas of medicine, prevention is aspirational.
In psychiatry and addiction medicine, prevention is exponential in its impact.
By the time a young adult presents with a fully developed mood disorder or substance use disorder, the trajectory has often been unfolding for years — shaped by neurobiology, stress exposure, reward circuitry, impulsivity, social dynamics, and environment. The pathology rarely begins at diagnosis.
When we educate students early — explaining the neuroscience of the developing brain, the vulnerability of dopaminergic pathways, the interface between anxiety, depression, and substance exposure, and the long‑term consequences of high‑risk behaviors — we are not simply providing information. We are influencing developmental trajectories.
This year, I approached the seminars differently.
Nine brilliant high school students joined me as co‑presenters, helping deliver critical messages to their peers. The impact was profound.
When complex neurobiological concepts and discussions about addiction risk are delivered not only by a physician, but also by trusted peer leaders, the message resonates at an entirely different level. Knowledge transmitted peer‑to‑peer carries credibility, relatability, and cultural fluency that no adult voice alone can replicate.
The result was a far more engaged, reflective, and dynamic dialogue with the audience.
Adolescents are capable of sophisticated understanding when we respect their intellectual capacity. The students at Calverton were inquisitive, thoughtful, and ambitious — asking nuanced questions about vulnerability, resilience, autonomy, and long‑term outcomes.
If we are serious about reducing the future burden of psychiatric illness and addiction, the work begins well before crisis, well before treatment resistance, and well before formal diagnosis.
Prevention in our field is not secondary care.
It is strategic, high‑level medicine at its most impactful stage.
Dr. Venera Miller
; ; ;
;
